Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 501–600 of 786
Tiwari, S., Goel, G., & Kumar, A. (2022) · International Reviews of Immunology · doi:10.1080/08830185.2022.2089666 · Cited by 9
Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice
Kim, E.-H., Lee, B.-W., Ryu, B., Cho, H. M., Kim, S., Jang, S., Casel, M. A. B., Rollon, R., Yoo, J., Poo, H., et al. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105371 · Cited by 10
Pathogenesis of viral infection
Zai, W., & Yuan, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00033-2 · Cited by 9
SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte fusionPreprint
Schneider, J. W., Pease, D. R., Navaratnarajah, C. K., Halfmann, P., Clemens, D. J., Ye, D., Kim, C., Barkhymer, A. J., Cohle, S. D., Banks, A., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-95587/v1 · Cited by 13
van Oosterhout, C., Stephenson, J. F., Weimer, B. C., Ly, H., Hall, N., & Tyler, K. M. (2021) · Virulence · doi:10.1080/21505594.2021.1960109 · Cited by 9
Qi, Q., Chen, Q., Dong, Y., Wang, K., Wang, J., Jin, G., Zheng, A., Zhang, R., Deng, Y., Li, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01483-8 · Cited by 8
Self-citationCao, J.-B., Zhu, S.-T., Huang, X., Wang, X.-Y., Wu, M., Li, X., Liu, F., Chen, L., Zheng, Y., & Wang, J. (2024) · Virologica Sinica · doi:10.1016/j.virs.2024.03.001 · Cited by 9
Self-citationSanchez-Martinez, Z. V., Alpuche‐Lazcano, S. P., Stuible, M., Akache, B., Renner, T. M., Deschatelets, L., Dudani, R., Harrison, B. A., McCluskie, M. J., Hrapovic, S., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126463 · Cited by 8
Self-citationBeltrami, V. A., Martins, F. R. B., Martins, D. G., Queiroz‐Junior, C. M., Félix, F. B., Resende, L. C., Santos, F. R. D. S., Lacerda, L. D. S. B., Costa, V. R. D. M., da Silva, W. N., et al. (2025) · Inflammation Research · doi:10.1007/s00011-024-01985-3 · Cited by 8
Chakraborty, C., Lo, Y.-H., Bhattacharya, M., Das, A., & Wen, Z. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102527 · Cited by 10
Update on animal models for COVID‐19 research
Cleary, S. J., Magnen, M., Looney, M. R., & Page, C. P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15266 · Cited by 8
Jumping a Moving Train: SARS-CoV-2 Evolution in Real Time
Moustafa, A. M., & Planet, P. J. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab051 · Cited by 8
Alabbas, A. B., & Alamri, M. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.09.028 · Cited by 8
Ahmed, S. S., Al-Mamun, A., Hossain, S. I., Akter, F., Ahammad, I., Chowdhury, Z. M., & Salimullah, M. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2111361 · Cited by 8
A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains
Nakandakari-Higa, S., Parsa, R., Reis, B. S., de Carvalho, R. A., Mesin, L., Hoffmann, H.-H., Bortolatto, J., Muramatsu, H., Lin, P. J. C., Bilate, A. M. B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007080 · Cited by 8
A highly susceptible hACE2-transgenic mouse model for SARS-CoV-2 research
Liu, G., Zhang, M., Wu, B., Zhang, C., Wang, Y., Han, X., Wang, R., Li, L., Wei, Y., Sun, Y., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1348405 · Cited by 10
Self-citationGenetic Path of the Emergence of SARS-CoV-2
Nasrin, T., & Ali, S. (2021) · Gene Cell and Tissue · doi:10.5812/gct.118302 · Cited by 8
Susceptibility to SARS-CoV-2 Virus Variants of Concern in Mouse Models
Shipovalov, A. V., Kudrov, G. A., Томилов, А., Боднев, С. А., Boldyrev, N. D., Ovchinnikova, A. S., Zaikovskaya, A. V., Taranov, O. S., Pyankov, O. V., Maksyutov, R. A., et al. (2022) · Problems of Particularly Dangerous Infections · doi:10.21055/0370-1069-2022-1-148-155 · Cited by 8
An Engineered IgG–VHH Bispecific Antibody against SARS‐CoV‐2 and Its Variants
Chi, H., Wang, L., Liu, C., Cheng, X., Zheng, H., Lv, L., Tan, Y., Zhang, N., Zhao, S.-Q., Wu, M., et al. (2022) · Small Methods · doi:10.1002/smtd.202200932 · Cited by 9
Self-citationCurrent state-of-the-art and potential future therapeutic drugs against COVID-19
Sha, A., Liu, Y., & Hao, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1238027 · Cited by 8
Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
Adams, L. E., Dinnon, K. H., Hou, Y. J., Sheahan, T. P., Heise, M. T., & Baric, R. S. (2021) · mBio · doi:10.1128/mbio.03149-20 · Cited by 8
MHC class I links with severe pathogenicity in C57BL/6N mice infected with SARS-CoV-2/BMA8
Qin, T., Shen, B., Li, E., Jin, S., Luo, R., Zhang, Y., Qi, J., Deng, X., Shi, Z., Wang, T., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02031-0 · Cited by 7
Self-citationLiu, R., Natekar, J. P., Kim, K., Pathak, H., Bhatnagar, N., Raha, J. R., Park, B. R., Guglani, A., Shin, C. H., Kumar, M., et al. (2024) · Vaccines · doi:10.3390/vaccines12040362 · Cited by 8
Anthroponosis and risk management: a time for ethical vaccination of wildlife?
Edwards, S., Chatterjee, H. J., & Santini, J. M. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00081-1 · Cited by 11
Zhang, M., Gong, Y., & Jiao, S. (2022) · Future Virology · doi:10.2217/fvl-2021-0100 · Cited by 7
Lacy, J., Mensah, A. A., Simmons, R., Andrews, N. J., Siddiqui, R., Bukasa, A., O’Boyle, S., Campbell, H., & Brown, K. E. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822000966 · Cited by 7
Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview
Hadizadeh, N., Naderi, M., Khezri, J., Yazdani, M., Shamsara, M., & Hashemi, E. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01002-6 · Cited by 8
Huang, A. C., Lin, S., Chiu, T.-H., Chang, K., Huang, T., Yang, T.-H., Shiao, Y.-H., Lee, C.-S., Chung, F., & Chiu, C. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.76725 · Cited by 7
Yu, W., Wang, J., Yang, Y., Tang, C., Yang, C., Li, B., Wang, H., Zhou, Y., Huang, Q. M., Yang, H. Y., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28846 · Cited by 7
Self-citationAdaptation of SARS-CoV-2 to ACE2 H353K mice reveals new spike residues that drive mouse infection
Li, K., Verma, A., Li, P., Ortiz, M. E., Hawkins, G. M., Schnicker, N., Szachowicz, P. J., Pezzulo, A. A., Wohlford-Lenane, C., Kicmal, T., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01510-23 · Cited by 10
Immune evasion, infectivity, and membrane fusion of the SARS-CoV-2 JN.1 variant
Tang, H., Zhuo, Y., Chen, J., Zhang, R., Zheng, M., Huang, X., Chen, Y., Huang, M., Zeng, Z., Huang, X., et al. (2025) · Virology Journal · doi:10.1186/s12985-025-02737-3 · Cited by 7
Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic
Wang, R., Stephen, P., Tao, Y., Zhang, W., & Lin, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111232 · Cited by 7
Up or down: where comes Omicron?
Liu, Z., Lu, L., & Jiang, S. (2022) · Cell Research · doi:10.1038/s41422-022-00675-1 · Cited by 8
Self-citationProteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage
Wang, T., Miao, F., Lv, S., Li, L., Feng, W., Hou, L., Sun, R., Li, W., Zhang, J., Zhang, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954121 · Cited by 7
Self-citationZhao, S., Ran, J., & Han, L. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0412 · Cited by 7
Andreotti, S., Altmüller, J., Quedenau, C., Borodina, T. A., Nouailles, G., Alves, L. G. T., Landthaler, M., Bieniara, M., Trimpert, J., & Wyler, E. (2022) · Genome Biology and Evolution · doi:10.1093/gbe/evac100 · Cited by 8
Liu, Y., Kumblathan, T., Joyce, M., Tyrrell, D. L., Tipples, G. A., Pang, X., Li, X., & Le, X. C. (2023) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.3c00005 · Cited by 7
Self-citationProspects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
Wei, X., Rong, N., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993754 · Cited by 6
Sun, Q., Huang, Z.-Q., Yang, S., Li, Y., Ma, Y., Yang, F., Zhang, Y., & Xu, F. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152287 · Cited by 9
Self-citationHow Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?
Pons, S., Uhel, F., Frapy, E., Sérémé, Y., Zafrani, L., Aschard, H., & Skurnik, D. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10477-y · Cited by 6
Barreto-Vieira, D. F., Bandeira, D. M., da Silva, M. A. N., de Almeida, A. L. T., Araújo, M., Machado, A. B., Tort, L. F. L., Nacife, V. P., Siqueira, M. M., Motta, F. C., et al. (2023) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2023.103706 · Cited by 6
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV
Guo, H., Cho, B., Hinton, P. R., He, S., Yu, Y., Ramesh, A. K., Sivaccumar, J. P., Ku, Z., Campo, K., Holland, S., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2275598 · Cited by 8
Self-citationAloufi, A. S., El‐Arabey, A. A., Eltayb, W. A., Elsayim, R., Marenga, H. S., Modafer, Y., Awadalla, M., Mohapatra, P. K., Mohapatra, R. K., & Abdalla, M. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2314745 · Cited by 6
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Zheng, H., 中国科学院昆明动物研究所遗传资源与进化国家重点实验室, 生., Song, T., Zheng, Y., & 中国科学院昆明动物研究所模式动物表型与遗传研究国家重大科技基础设施(灵长类设施), 国. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2024.062 · Cited by 6
Wang, J. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00691-4 · Cited by 6
Tamura, Y., Jee, E., Kouzaki, K., Kotani, T., & Nakazato, K. (2021) · Physiological Reports · doi:10.14814/phy2.15014 · Cited by 6
Immune responses to human respiratory coronaviruses infection in mouse models
Zhuang, Z., Liu, D., Sun, J., Li, F., & Zhao, J. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.11.015 · Cited by 7
Nanomechanical analysis of SARS-CoV-2 variants and predictions of infectiousness and lethality
Hu, Y., & Buehler, M. J. (2022) · Soft Matter · doi:10.1039/d1sm01181b · Cited by 6
A Protein Co-Conservation Network Model Characterizes Mutation Effects on SARS-CoV-2 Spike Protein
Zeng, L., Lu, Y., Yan, W., & Yang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043255 · Cited by 6
Gong, B., Wang, L., Zhang, H., Wang, Q., & Li, W. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3925 · Cited by 6
Yu, J., Azzam, E. I., Jadhav, A. B., & Wang, Y. (2021) · Cells · doi:10.3390/cells10092212 · Cited by 6
Self-citationWu, S., Li, Y., Mishra, S., Bodner, K., Baral, S., Kwong, J. C., & Wei, X. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.11.028 · Cited by 6
Self-citationHomma, T., Nagata, N., Hashimoto, M., Iwata‐Yoshikawa, N., Seki, N. M., Shiwa-Sudo, N., Ainai, A., Dohi, K., Nikaido, E., Mukai, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25418-5 · Cited by 6
Clinical grade ACE2 effectively inhibits SARS-CoV-2 Omicron infectionsPreprint
Monteil, V., Devignot, S., Klingström, J., Thålin, C., Kellner, M. J., Christ, W., Havervall, S., Mereiter, S., Knapp, S., Montserrat, N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.25.474113 · Cited by 6
Zhang, G., Wang, Q., Ji, K., Wang, Y., Xu, W., Zhou, J., Liu, Z., Xiu, R., Xing, L., Zhou, J., et al. (2025) · MedComm · doi:10.1002/mco2.70273 · Cited by 5
Self-citationJefferies, W. A., Choi, K. B., Ribeca, P., Kari, S., Young, J. B., Hui, E., Qi, S. Y., Garrovillas, E., Fan, J., Cho, B. M. Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66252-3 · Cited by 5
Worldwide SARS-CoV-2 haplotype distribution in early pandemic
Cairo, A., Iorio, M. V., Spena, S., Tagliabue, E., & Peyvandi, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263705 · Cited by 5
Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
Yao, W., Li, Y., Ma, D., Hou, X.-D., Wang, H., Tang, X., Cheng, D., Zhang, H., Du, C., Pan, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02676-23 · Cited by 6
Self-citationShukla, N., Roelle, S. M., Snell, J. C., DelSignore, O., Bruchez, A. M., & Matreyek, K. A. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012044 · Cited by 6
Chen, Z., Cui, Q., Yan, R., Achi, J. G., Chen, Z., Rong, L., & Du, R. (2024) · Journal of Virology · doi:10.1128/jvi.00504-24 · Cited by 6
A humanized ACE2 mouse model recapitulating age‐ and sex‐dependent immunopathogenesis of COVID‐19
Park, U., Lee, J. H., Kim, U., Jeon, K., Kim, Y., Kim, H. R., Kang, J.-I., Park, M. Y., Park, S. H., Cha, J. S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29915 · Cited by 6
Ma, Y.-F., Chen, K., Xie, B., Zhu, J., He, X., Chen, C., Yang, Y. R., & Liu, Y. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2447615 · Cited by 5
Rombel‐Bryzek, A., Petkov, P., Lilkova, E., Ilieva, N., Litov, L., Kubus, M., & Witkowska, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094064 · Cited by 5
Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro
Wang, G., Guan, J., Li, G., Wu, F., Yang, Q., Huang, C., Shao, J., Xu, L., Guo, Z., Zhou, Q., et al. (2021) · Disease Markers · doi:10.1155/2021/6803510 · Cited by 5
Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection
Jha, A., Barker, D., Lew, J. M., Manoharan, V. K., van Kessel, J., Haupt, R. E., Toth, D., Frieman, M. B., Falzarano, D., & Kodihalli, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-21223-2 · Cited by 5
In Vivo Models for Evaluation of Drug Efficacy: Demand and Challenges
Asthana, S., Shukla, V., & Tripathi, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-7952-1_5 · Cited by 5
Wang, Y., Ye, M., Zhang, F., Freeman, Z. T., Yu, H. J., Ye, X., & He, Y. O. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295541 · Cited by 5
Self-citationDevelopment of a Mouse-Adapted Reporter SARS-CoV-2 as a Tool for Two-Photon In Vivo Imaging
Ueki, H., Kiso, M., Furusawa, Y., Iida, S., Yamayoshi, S., Nakajima, N., Imai, M., Suzuki, T., & Kawaoka, Y. (2024) · Viruses · doi:10.3390/v16040537 · Cited by 5
Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice
Pan, R., Li, P., Meyerholz, D. K., & Perlman, S. M. (2024) · Journal of Virology · doi:10.1128/jvi.00584-24 · Cited by 5
Variants of SARS Coronavirus-2 and Their Potential Impact on the Future of the COVID-19 Pandemic
Li, X., To, K. K., & Yuen, K. (2021) · Zoonoses · doi:10.15212/zoonoses-2021-1003 · Cited by 5
Self-citationZhang, L., Chen, S., Zhang, W., Yang, H., Jin, Y., & Duan, G. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770935 · Cited by 5
Self-citationShi, J., Jin, X., Ding, Y., Liu, X. K., Shen, A., Wu, Y., Peng, M., & Shen, C. (2021) · Vaccines · doi:10.3390/vaccines9121383 · Cited by 5
Onen, E. A., Sönmez, K., Yıldırım, F., Demirci, E., & Gürel, A. (2022) · All Life · doi:10.1080/26895293.2022.2099468 · Cited by 7
Khalaf, R. A., Bernasconi, A., Pinoli, P., & Ceri, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.051 · Cited by 5
Sun, C., Chi, H., Yuan, F., Li, J., Yang, J., Zheng, A., Wang, F., Sun, L., Zhang, Y., Hu, P. F., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2166-y · Cited by 5
Self-citationLuo, D., Li, T., Yang, X., Ning, N., Zhang, L., Gu, H., Li, D., Yu, W., Hu, Z., & Wang, H. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28359 · Cited by 5
Self-citationSARS-CoV-2-related vascular injury: mechanisms, imaging and models
Humayun, L. L., Smith, C. P. S., Li, W., Zhang, Y. S., Park, C., Feng, W., & Yao, J. (2021) · Microphysiological Systems · doi:10.21037/mps-20-6 · Cited by 5
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
Maen, A., Yavuz, B. G., Mohamed, Y. I., Esmail, A., Lu, J., Mohamed, A., Azmi, A. S., Kaseb, M., Kasseb, O. O., Li, D., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1291212 · Cited by 5
Metzdorf, K., Jacobsen, H., 김연수, Alves, L. G. T., Kulkarni, U., Eschke, K., Chaudhry, M. Z., Hoffmann, M., Bertoglio, F., Ruschig, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1383086 · Cited by 4
An outbreak of SARS-CoV-2 omicron variant and deaths of three lions in a zoo
Kuroda, Y., Ozaki, M., Sakai, Y., Uchida‐Fujii, E., HANADA, I., Yamamoto, T., Tatemoto, K., Hirata, Y., Sato, Y., Katano, H., et al. (2024) · One Health · doi:10.1016/j.onehlt.2024.100870 · Cited by 4
Cross-Neutralizing Activity of Monoclonal Antibodies Against N501Y Mutant Strain of SARS-CoV-2
Ding, R., Wang, H., Yang, Y., Xie, L., Zhang, L., Li, Q., Liu, S., Nie, J., Wu, J., Qin, H., et al. (2020) · Journal of Applied Virology · doi:10.21092/jav.v9i4.90 · Cited by 4
Self-citationFerrareze, P. A. G., Zimerman, R. A., Franceschi, V. B., Caldana, G. D., Netz, P. A., & Thompson, C. E. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2076154 · Cited by 6
Luo, D., Pan, H., He, P., Yang, X., Li, T., Ning, N., Fang, X. D., Yu, W., Wei, M., Gao, H., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1016 · Cited by 4
Self-citationHe, W., Cui, H. Y., Wang, S., Liang, B., Zhang, C., Wang, W., Wang, Q. M., Li, W., Zhao, Y., Wang, T., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11020431 · Cited by 4
The binding and structural basis of fox ACE2 to RBDs from different sarbecoviruses
Chen, J. D. Z., Sun, J., Xu, Z., Li, L., Kang, X., Luo, C., Wang, Q. M., Guo, X., Li, Y., Liu, K., et al. (2024) · Virologica Sinica · doi:10.1016/j.virs.2024.06.004 · Cited by 4
Self-citationImpact of Missense Mutations on Spike Protein Stability and Binding Affinity in the Omicron Variant
Mahase, V., Sobitan, A., Yao, Q., Shi, X. M., Qin, H. H., Kidane, D., Tang, Q., & Teng, S. (2024) · Viruses · doi:10.3390/v16071150 · Cited by 4
York, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0424-x · Cited by 4
SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan
Khan, A., Hanif, M., Syed, S., Ahmed, A., Ghazali, S., & Khanani, R. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.724208 · Cited by 4
Singh, S. K., Kumar, A., & Sharma, H. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220124101611 · Cited by 4
Wang, H., Zhang, L., Liang, Z.-T., Nie, J., Wu, J.-J., Li, Q.-Q., Ding, R., Zhang, Y., Chen, G., Wang, Y., et al. (2022) · Archives of Virology · doi:10.1007/s00705-021-05327-0 · Cited by 5
Self-citationLin, H., Liu, M., Jiang, R.-D., Gong, Q.-C., Su, J., Guo, Z.-S., Chen, Y., Jia, J.-K., Dong, T.-Y., Zhu, Y., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00790-23 · Cited by 4
Self-citationCalcagnile, M., Forgez, P., Alifano, M., & Alifano, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.12.426365 · Cited by 4
Thornlow, B. P., Hinrichs, A. S., Jain, M., Dhillon, N., La, S., Kapp, J. D., Anigbogu, I., Cassatt‐Johnstone, M., McBroome, J., Haeussler, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.05.438352 · Cited by 4
Role of N501Y Mutation in SARS-CoV-2 Spike Protein StructurePreprint
Roy, U. (2021) · Preprints.org · doi:10.20944/preprints202106.0238.v1 · Cited by 4
Linking genomic and epidemiologic information to advance the study of COVID-19
Wang, Y., Yang, J., Zhuang, X., Ling, Y., Cao, R., Xu, Q., Wang, P., Xu, P., & Zhang, G. (2022) · Scientific Data · doi:10.1038/s41597-022-01237-1 · Cited by 6
Self-citationSun, S., He, L., Zhao, Z., Gu, H., Fang, X. D., Wang, T., Yang, X., Chen, S., Deng, Y., Li, J., et al. (2020) · Research Square · doi:10.1101/2020.11.29.402339 · Cited by 4
Self-citation(2022) · Asian Journal of Agriculture and Biology · doi:10.35495/ajab.2022.106 · Cited by 3
A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms
Huang, X., Li, Y., Deng, J., Tan, X., Yang, S., Liu, J., Wu, Z., Shi, P., Zhou, L., & Chen, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02640-5 · Cited by 4
Self-citationSex differences in coronavirus disease 2019 myocarditis
Beetler, D. J., & Fairweather, D. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100704 · Cited by 3
The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2
Khalid, K., Lim, H. X., Hwang, J. S., & Poh, C. L. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00963-1 · Cited by 3
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.